Journal article
Pilocarpine toxicity and the treatment of xerostomia
The Journal of emergency medicine, v 26(4), pp 429-432
2004
PMID: 15093850
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Pilocarpine has been used as an ophthalmologic agent for decades; however, toxicity rarely has been reported in the medical literature. Oral pilocarpine tablets, as well as another muscarinic agent (cevimeline), have recently been approved for the treatment of dry mouth (xerostomia). We report a case of unintentional overdose of oral pilocarpine tablets that resulted in bradycardia, mild hypotension, and muscarinic symptoms in a patient with Sjogren's syndrome. The patient's symptoms were relieved with 0.5 mg intravenous atropine and she recovered uneventfully. The case is unique in that it is the first reported ingestion of oral pilocarpine tablets and the first dosing error reported for this indication. In addition, this case underscores the importance of communication between physician and patient and the resulting toxicity related to miscommunication.
Metrics
Details
- Title
- Pilocarpine toxicity and the treatment of xerostomia
- Creators
- Robert G Hendrickson - Oregon Health & Science UniversityAnthony P Morocco - Department of Emergency Medicine, Guam Memorial Hospital, Agana, GuamMichael I Greenberg - Drexel University
- Publication Details
- The Journal of emergency medicine, v 26(4), pp 429-432
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Emergency Medicine
- Web of Science ID
- WOS:000220938800009
- Scopus ID
- 2-s2.0-1942452258
- Other Identifier
- 991019169651804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Emergency Medicine